Roivant Sciences (ROIV) Research & Development (2020 - 2025)

Roivant Sciences' Research & Development history runs 6 years deep, the most recent figure standing at $482.9 million for Q4 2025.

• Quarterly Research & Development rose 19.17% year-over-year to $482.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 billion (up 20.42% YoY) and the FY2026 annual result came in at $681.8 million, up 23.87% from the prior year.
• Research & Development was $482.9 million for Q4 2025 at Roivant Sciences, up from $164.6 million in the prior quarter.
• Across five years, Research & Development topped out at $482.9 million in Q4 2025 and bottomed at $78.5 million in Q2 2021.
• A 5-year average of $217.4 million and a median of $143.1 million in 2024 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development surged 73.0% — and 2023, when it declined 15.51%.
• Roivant Sciences' Research & Development stood at $348.0 million in 2021, then increased by 13.05% to $393.4 million in 2022, then decreased by 15.51% to $332.4 million in 2023, then increased by 21.91% to $405.2 million in 2024, then advanced by 19.17% to $482.9 million in 2025.
• Business Quant data shows ROIV's Research & Development at $482.9 million in Q4 2025, $164.6 million in Q3 2025, and $152.9 million in Q2 2025.